Chaopin Yang

Sun Yat-sen University — China

Medicine · Health Sciences

16h-index1.2kcitations34works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(6), CAR-T cell therapy research(5), Immune Cell Function and Interaction(4), Identification and Quantification in Food(4), Lung Cancer Diagnosis and Treatment(3)

Publications34 total

Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma
Journal of Hematology & Oncology·2023· 1 citedOpen Access
Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma
BMC Medicine·2023· 34 citedOpen Access
Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma
Frontiers in Immunology·2023· 24 citedOpen Access
BMP9‐induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus‐associated hepatocellular carcinoma
Clinical and Translational Medicine·2023· 4 citedOpen Access
Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer
Frontiers in Immunology·2022· 7 citedOpen Access
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
Cell Death and Disease·2022· 44 citedOpen Access
CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype
Journal for ImmunoTherapy of Cancer·2022· 156 citedOpen Access
SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway
International Journal of Biological Sciences·2022· 39 citedOpen Access
Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin
Cell Death and Disease·2021· 29 citedOpen Access
Phase II trial of toripalimab plus chemotherapy as neoadjuvant treatment in resectable stage III non-small cell lung cancer (NeoTPD01 Study).
Journal of Clinical Oncology·2021· 13 cited
Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression
Hepatology·2021· 321 cited
Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer
OncoImmunology·2021· 119 citedOpen Access
Neoadjuvant Toripalimab with Chemotherapy is Feasible for Resectable Stage III Non-Small-Cell Lung Cancer: A Single-Arm, Phase 2 Trial
SSRN Electronic Journal·2021Open Access
The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
Clinical & Translational Immunology·2021· 9 citedOpen Access
The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors
Molecular Cancer·2020· 124 citedOpen Access
Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma
British Journal of Cancer·2020· 98 citedOpen Access
Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection
OncoImmunology·2020· 21 citedOpen Access
Overview of Strategies to Improve Therapy against Tumors Using Natural Killer Cell
Journal of Immunology Research·2020· 12 citedOpen Access
Severe delayed pulmonary toxicity following PD‐L1–specific CAR‐T cell therapy for non‐small cell lung cancer
Clinical & Translational Immunology·2020· 24 citedOpen Access
Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma
Aging·2019· 36 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Qiuzhong Pan(15), Jian‐Chuan Xia(15), Desheng Weng(14), Jieying Yang(13), Mengjia Song(10), Yan Tang(10), Yulong Han(10), Tong Xiang(10), Yue Huang(9), Qijing Wang(8), Yongqiang Li(8), Junyi He(7), Jingjing Zhao(7), Jia He(7), Jingjing Zhao(5), Jianxiong Zeng(4), Jinqi You(4), Yizhi Wang(4), Ziqi Zhou(4), Qian Zhu(4)